Drug Class: Selective Estrogen Receptor Modulator (SERM)
Composition: Tamoxifen Citrate
Dosage: 20 mg/tablet
Form: Oral Tablet
Unit: 50 Tablets
Brand: British Dragon
For Oral Administration
British Dragon Tamoxifen, containing 20mg of Tamoxifen Citrate (commonly known as Nolvadex), serves as one of the most versatile and essential compounds in responsible performance enhancement. Unlike aromatase inhibitors that reduce overall estrogen production, Tamoxifen works as a Selective Estrogen Receptor Modulator (SERM) by blocking estrogen receptors in specific tissues while acting as an estrogen agonist in others. This unique mechanism makes it invaluable for two critical purposes: preventing and reversing gynecomastia during cycles, and stimulating natural testosterone production during post-cycle therapy (PCT). The 20mg tablet strength provides optimal dosing flexibility for both applications, making Tamoxifen a cornerstone of both cycle safety and recovery protocols for knowledgeable athletes.
Tamoxifen exerts its effects through sophisticated tissue-selective estrogen receptor modulation. In breast tissue, it acts as a potent estrogen antagonist, binding to estrogen receptors and preventing actual estrogen from activating them—this is the mechanism that makes it so effective against gynecomastia. Meanwhile, in the liver, it acts as an estrogen agonist, providing beneficial effects on cholesterol profiles. Most importantly for post-cycle recovery, in the pituitary gland it blocks estrogen's negative feedback, tricking the body into increasing production of Gonadotropin-Releasing Hormone (GnRH), which stimulates Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) release. This complex mechanism allows Tamoxifen to provide targeted estrogen blockade where it's needed most while avoiding the systemic estrogen suppression that can cause joint pain and lipid issues associated with aromatase inhibitors.
The 20mg tablet strength of Tamoxifen allows for precise dosing across different applications:
Gynecomastia Prevention During Cycle:
Gynecomastia Reversal:
Post-Cycle Therapy (Standard Protocol):
Duration depends on application: throughout cycles for gyno prevention, or 4-6 weeks for PCT protocols.
Tamoxifen integrates into both on-cycle protection and post-cycle recovery strategies:
On-Cycle Gynecomastia Protection:
Comprehensive Post-Cycle Therapy:
For those using compounds like Trenabol 100 that can cause progesterone-related gyno, Tamoxifen alone may not be sufficient—consider adding Mesterolone for additional protection.
While Tamoxifen is generally well-tolerated, some users may experience side effects:
Most side effects are dose-dependent and diminish with continued use or dosage adjustment.
Understanding how Tamoxifen compares to other estrogen management options is crucial for proper use. Compared to Anastrozole (an aromatase inhibitor), Tamoxifen doesn't reduce overall estrogen levels but rather blocks its effects in specific tissues—this makes it superior for gynecomastia but less effective for controlling water retention and blood pressure. Versus Clomiphene (another SERM), Tamoxifen is more effective for gynecomastia prevention and has a better side effect profile for most users, while Clomiphene may be slightly more effective for stimulating LH production during PCT. Many advanced users combine Tamoxifen with aromatase inhibitors for comprehensive estrogen management—blocking estrogen effects in breast tissue while reducing overall estrogen levels systemically.
For those particularly prone to gynecomastia, a sophisticated approach to Tamoxifen use is essential:
This comprehensive approach provides maximum protection against this common and concerning side effect.
Maximizing the effectiveness of Tamoxifen in PCT requires careful planning and execution:
Optimal PCT Timing:
Supportive Measures During PCT:
Success Indicators:
This comprehensive approach ensures the best possible recovery of natural hormonal function.
Name: Tamoxifen
Drug Class: Selective Estrogen Receptor Modulator (SERM)
Other common names and terms: Nolvadex, Tamoxifen Citrate
Active Life: 5-7 days
Detection Time: 2-3 weeks
Chemical Structure: (Z)-2-[4-(1,2-diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine
Common Doses: 10-40 mg daily (depending on application)
Blood pressure: No significant effect
Acne: Can improve as hormones stabilize
Water retention: Minimal effect on water retention
Aromatisation: Does not aromatize
Liver toxicity: Low to moderate at high doses
Decrease HPTA function: No, stimulates HPTA function during PCT
While Tamoxifen can be used during your cycle for gynecomastia prevention, it's not a complete substitute for an aromatase inhibitor. Tamoxifen only blocks estrogen receptors in certain tissues—it doesn't reduce overall estrogen levels in your body. This means it won't help with estrogen-related water retention, high blood pressure, or the negative feedback that can suppress your natural testosterone production during a cycle. For comprehensive estrogen control, many users run both an AI like Anastrozole (to control estrogen levels) and Tamoxifen (to protect breast tissue specifically).
Tamoxifen begins working within hours of your first dose, but tangible improvement in gynecomastia symptoms typically takes 3-7 days. Early-stage symptoms (puffiness, sensitivity, itching) usually resolve within 1-2 weeks at 20mg daily. More established gyno with palpable glandular tissue may take 3-6 weeks to significantly reduce, and in some cases of long-standing fibrous tissue, complete reversal may not be possible. For fastest results, combine Tamoxifen with an aromatase inhibitor and begin treatment at the very first signs of symptoms rather than waiting for development of hard tissue.
Both Clomiphene (Clomid) and Tamoxifen are SERMs used in PCT, but they have different strengths. Clomiphene is generally considered slightly more effective for stimulating LH production and restarting the HPTA axis. Tamoxifen is more effective for blocking estrogen receptors in breast tissue and may have a better side effect profile for most users. Many advanced users take both simultaneously during PCT—Clomiphene for primary HPTA recovery and Tamoxifen for estrogen control and gyno prevention. They work through slightly different mechanisms and complement each other well in a comprehensive PCT protocol.
While Tamoxifen is prescribed to women for medical purposes (primarily breast cancer treatment and prevention), it's generally not recommended for female bodybuilding use. The hormonal effects can be unpredictable and may cause significant side effects including severe menopausal symptoms, ovarian cysts, and menstrual irregularities. Female athletes seeking performance enhancement are better served by milder compounds like Oxanabol (Anavar) or Primobol at appropriate female doses. If women do use Tamoxifen, it should be under medical supervision and for specific therapeutic purposes only.
Standard PCT protocols typically last 4-6 weeks, after which Tamoxifen should be discontinued. There's generally no benefit to extending Tamoxifen use beyond this point, and prolonged use increases the risk of side effects without additional recovery benefits. However, if you're still experiencing low testosterone symptoms after completing PCT, it's better to get blood work to assess your hormonal status rather than arbitrarily extending Tamoxifen use. In some cases of particularly suppressive cycles, some users extend to 8 weeks, but this should be based on blood work rather than guesswork. After PCT, focus on natural recovery support rather than continued SERM use.
Please log in to write Tamoxifen 20 mg review.